Which has the lower trailing P/E, ABT or BMY?

BMY has the lower trailing P/E: ABT trades at 33.96 and BMY at 14.39. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABT or BMY?

Over the past five years, ABT grew revenue faster — ABT at a 2.98% CAGR versus BMY at 2.08%.

Does ABT or BMY pay a bigger dividend?

ABT yields 2.31% and BMY yields 2.88% based on trailing dividends and the latest price.

Is ABT or BMY more profitable?

BMY runs the higher net margin — ABT at 11.65% versus BMY at 18.87%.

How have ABT and BMY total returns compared?

Over the past 10 years, ABT delivered 11.02% and BMY delivered 2.19% annualized total return. Past performance doesn't predict future results.

Abbott Laboratories (ABT) vs Bristol-Myers Squibb Company (BMY)

A side-by-side comparison of Abbott Laboratories and Bristol-Myers Squibb Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.

ABT

Abbott Laboratories

$184.11B

$105.70HealthcareDelayed quote: Jul 31, 2026, 4:02 PM EDT

BMY

Bristol-Myers Squibb Company

$133.37B

$65.31HealthcareAt close: Jul 31, 2026, 4:00 PM ET

Total return — ABT vs BMY

growth of $100 · dividends reinvested · last 30y

ABT +1948.2%BMY +807.5%ABT compounded faster

ABT BMY

ABT vs BMY: by the numbers

•ABT is the larger company ($184.11B vs $133.37B market cap).
•BMY trades at the lower trailing earnings multiple (14.39 vs 33.96 P/E), one valuation lens rather than an overall verdict.
•BMY converts more revenue to profit (18.87% vs 11.65% net margin).
•ABT grew revenue faster over the past five years (2.98% vs 2.08% CAGR).
•BMY pays the higher dividend yield (2.88% vs 2.31%).

Metrics side by side

Valuation

Metric	ABT	BMY
P/E ratio	33.96	14.39
Forward P/E	19.15	9.88
P/S ratio	3.95	2.72
P/B ratio	3.54	5.99
PEG ratio	4.13	1.53
EV / EBITDA	21.37	9.93
FCF yield	4.00%	9.20%

Profitability

Metric	ABT	BMY
Gross margin	56.80%	70.16%
Operating margin	17.03%	28.27%
Net margin	11.65%	18.87%
ROE	10.42%	41.59%
ROIC	8.43%	13.90%

Dividends

Metric	ABT	BMY
Dividend yield	2.31%	2.88%
Payout ratio	65.24%	54.34%

Growth (annualized)

Metric	ABT	BMY
Revenue CAGR (5Y)	2.98%	2.08%
EPS CAGR (5Y)	8.22%	9.38%
FCF CAGR (5Y)	5.26%	-0.69%
Total return CAGR (5Y)	-0.78%	3.38%

Frequently asked

Which has the lower trailing P/E, ABT or BMY?: BMY has the lower trailing P/E: ABT trades at 33.96 and BMY at 14.39. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABT or BMY?: Over the past five years, ABT grew revenue faster — ABT at a 2.98% CAGR versus BMY at 2.08%.
Does ABT or BMY pay a bigger dividend?: ABT yields 2.31% and BMY yields 2.88% based on trailing dividends and the latest price.
Is ABT or BMY more profitable?: BMY runs the higher net margin — ABT at 11.65% versus BMY at 18.87%.
How have ABT and BMY total returns compared?: Over the past 10 years, ABT delivered 11.02% and BMY delivered 2.19% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABT analysis Full BMY analysis Interactive comparison tool

Dig into the metrics

Abbott Laboratories P/E ratio Bristol-Myers Squibb P/E ratio Abbott Laboratories dividend yield Bristol-Myers Squibb dividend yield Abbott Laboratories ROE Bristol-Myers Squibb ROE Abbott Laboratories operating margin Bristol-Myers Squibb operating margin Abbott Laboratories revenue growth Bristol-Myers Squibb revenue growth Abbott Laboratories free cash flow Bristol-Myers Squibb free cash flow

Abbott Laboratories & Bristol-Myers Squibb appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.